• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Avid Radiopharmaceuticals - Articles and news items

FDA approves Amyvid™

Industry news, News / 6 April 2012 / Eli Lilly and Company

Amyvid is the first and only radioactive diagnostic agent approved for PET imaging of beta-amyloid neuritic plaques in the living brain…

Statement from Lilly and Avid on FDA Advisory Committee Recommendation for Amyvid(TM) (Florbetapir) NDA

Industry news, News / 20 January 2011 / Eli Lilly and Company

The U.S. FDA Peripheral and Central Nervous System Drugs Advisory Committee decided today that it could not recommend approval of Amyvid™ (florbetapir) at this time…